
An Australian research university with an exceptional commercialisation record in vaccines and biotechnology.
The University of Queensland has one of the strongest technology commercialisation records of any Australian institution, most notably through vaccine technology developed by its researchers and licensed globally.
It also has substantial mining, agricultural, and materials research reflecting Queensland's resource economy.
Brisbane's ecosystem is smaller than Sydney's or Melbourne's but has genuine depth in biotechnology, mining technology, and agricultural science.
Queensland state government has invested consistently in commercialisation infrastructure around the university.
Company formation concentrates in vaccines and therapeutics, diagnostics, mining technology, and agricultural science.
Its licensing income from vaccine technology is among the largest of any Australian university, and has funded further research.
Queensland operates state innovation funding, and the university's commercialisation arm invests directly in spinouts.
Sydney, Melbourne, and international life science investors participate in larger rounds.
GCN’s global network includes millions of startups and founders and a broad community of investors, creating opportunities to discover potential connections across university communities.
.png)




